In your mission to enrich worldwide quality of life via creation of innovative Pharmaceutical, Animal Health, Agrochemical and Food Products, there are challenges.
- A fact.
Attentive Science is a nimble Non-clinical Contract Research Organization (CRO) with the resources to support your mission. Our experienced scientists provide the highest quality results coupled with segment leading expediency and flexible solutions to meet your specific needs.
- Current State.
By choosing to partner with Attentive Science, your pipeline will reach its full potential by creating outcomes the world needs for a healthier future.
- The Future.
Visit us Virtually
As we all continue to live in a new norm,
we appreciate you cannot be here with us in person.
You will get an amazing experience if you visit virtually.
ALFRED BOTCHWAY PhD., DSP
Chief Executive Officer
Dr. Alfred Botchway has over 25 years’ experience including academic, pharmaceutical and contract research organization tenure performing research studies designed to; investigate pharmacokinetic / pharmacodynamics profiles, minimize potential toxic and/or undesirable effects of agrochemical, biotechnological and pharmaceutical products on physiological functions prior to administration to the intended population.
Dr. Botchway was the founder of Xenometrics a non-clinical contract research organization that provided pharmacokinetic, toxicological and safety pharmacology services to the biopharmaceutical and agrochemical industry. Subsequent to 12 years of successfully operating Xenometrics, Alfred exited Xenometrics a year after its sale to a multinational contract research organization. Alfred is an active member of several international scholastic professional scientific organizations. Alfred served as the President of the International Safety Pharmacology Society and continues to be an active Past President. Most recently, Alfred served as the interim President and Board Chair of BioKansas, a state trade organization for bioscience companies.
Dr. Botchway holds a Ph.D. in Cardiovascular Physiology from Imperial College of Science, Technology and Medicine, University of London, UK., and a Diplomate in Safety Pharmacology from the Society of Safety Pharmacology.
View in Profile
PHIL ATTERSON, BSc., MSc
Chief Operating Officer
Phil Atterson has over forty years of experience in non-clinical contract research organizations specializing primarily in toxicology and pharmacology.
He has held an increasing number of senior managerial positions at a number of global CRO’s including Huntingdon Research Centre, Quintiles, WIL Research, Xenometrics, Citoxlab USA.
Phil received his BSc and MSc in Pharmacology from the University of East London in the UK. He is a member of the Safety Pharmacology Society, Society of Toxicology, American College of Toxicology and the Japanese Society of Toxicology
View in Profile
Chief Culture Officer
Belinda serves as the Chief Culture Officer of Attentive Science and has over three decades of human resources experience.
Belinda is the CEO and founder of People People, a company that provides outsourced back-office HR services and has enabled several companies to scale and grow their business. Before starting her own company, she spent years handling human resources for a series of large, prestigious law firms.